Atlas Trials

A Clinical Study of TQB3454 Tablets in the Treatment of Advanced Biliary Carcinoma.

Clinical trial NCT05987358 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT05987358
Sponsor
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Biliary Carcinoma
Start date
2023-09-21
Primary completion
2026-12-01
Enrollment
165

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.